TLPH - TALPHERA, INC.
0.515
-0.025 -4.835%
Share volume: 34,522
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.02
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-13-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 4.237 M | 4.270 M | 3.749 M | |
| Selling general and admin | 2.804 M | 2.361 M | 1.696 M | |
| Research and development | 1.433 M | 1.909 M | 2.053 M | |
| Total expenses | 4.237 M | 4.270 M | 3.749 M | |
| 0.78% | -12.20% | |||
| Operating income | -4.237 M | -4.270 M | -3.749 M | |
| Ebit | -3.993 M | -3.815 M | -3.508 M | |
| Pretax income | -3.954 M | -3.827 M | -3.353 M | |
| -3.21% | -12.39% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -3.954 M | -3.827 M | -3.353 M | |
| 3.21% | 12.39% |
